Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of PARP Inhibitors in Glioblastoma and Perceiving Challenges as Well as Strategies for Successful Clinical Development
Priya Bisht, Vikash Kumar, Ruchi Pandey, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19

Showing 19 citing articles:

Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
Satya Siva Kishan Yalamarty, Nina Filipczak, Xiang Li, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2116-2116
Open Access | Times Cited: 107
Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 63
Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets
Ashley Irin Cortes Ballen, Maryam Amosu, Surya Ravinder, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1574-1574
Open Access | Times Cited: 6
Comparative Clinical-Imaging and Histogenetic Analysis Between Astrocytoma IDH-Mutant Grade 4 and Glioblastoma IDH-Wildtype—Is There Really a Worse One?
Cristian Ionuț Orășanu, Mariana Aşchie, Mariana Deacu, et al.
Diagnostics (2025) Vol. 15, Iss. 4, pp. 438-438
Open Access
Metabolic reprogramming in glioblastoma: a rare case of recurrence to scalp metastasis
Amir Barzegar Behrooz, Hamid Latifi-Navid, Narges Zolfaghari, et al.
BJC Reports (2025) Vol. 3, Iss. 1
Open Access
Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma
Amber B. Jones, Kaysaw Tuy, Cyntanna C. Hawkins, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2852-2852
Open Access | Times Cited: 3
Targeted therapies for Glioblastoma multiforme (GBM): State‐of‐the‐art and future prospects
S. Satish, Maithili Athavale, Prashant S. Kharkar
Drug Development Research (2024) Vol. 85, Iss. 7
Closed Access | Times Cited: 3
Naringin and temozolomide combination suppressed the growth of glioblastoma cells by promoting cell apoptosis: network pharmacology, in-vitro assays and metabolomics based study
Priya Bisht, Surendra Rajit Prasad, Khushboo Choudhary, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
The Potential of PARP Inhibitors as Antitumor Drugs and the Perspective of Molecular Design
Yinghan Wang, Jingtao Zhang, Xiaochen Wu, et al.
Journal of Medicinal Chemistry (2024) Vol. 68, Iss. 1, pp. 18-48
Closed Access | Times Cited: 2
BLM helicase overexpressed in human gliomas contributes to diverse responses of human glioma cells to chemotherapy
Kamil Wojnicki, Agnieszka Kaczmarczyk, Bartosz Wojtaś, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 4
HSPA5 and FGFR1 genes in the mesenchymal subtype of glioblastoma can improve a treatment efficacy
Ju Young Lee, Jongkeun Park, Dongwan Hong
Animal Cells and Systems (2024) Vol. 28, Iss. 1, pp. 216-227
Open Access | Times Cited: 1
Role of autophagy in modulating tumor cell radiosensitivity: Exploring pharmacological interventions for glioblastoma multiforme treatment
Pierre Bischoff, Jolie Bou-Gharios, G. Noël, et al.
Cancer/Radiothérapie (2024)
Open Access
New insight into targeting the DNA damage response in the treatment of glioblastoma
Tao Zhen, Tianyu Sun, Bin Xiong, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 10, pp. 869-886
Closed Access
PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives
Eugenia Cella, Alberto Bosio, Pasquale Persico, et al.
Cancer Treatment Reviews (2024) Vol. 131, pp. 102850-102850
Open Access
Role of BRCA1 in glioblastoma etiology
Emirhan Harbi, Michael Aschner
Cellular Oncology (2024)
Closed Access
Fuzzy time series forecasting based on adaptive radius clustering technique
Shivani Pant, Sanjay Kumar
AIP conference proceedings (2023) Vol. 2705, pp. 020001-020001
Closed Access | Times Cited: 1
BLM helicase determines chemotherapy-induced responses of human glioma cells and shifts between apoptosis, senescence or polyploidy
Kamil Wojnicki, Agnieszka Kaczmarczyk, Bartosz Wojtaś, et al.
Research Square (Research Square) (2023)
Open Access
BLM helicase overexpressed in human gliomas contributes to diverse responses of human glioma cells to chemotherapy
Kamil Wojnicki, Agnieszka Kaczmarczyk, Bartosz Wojtaś, et al.
Research Square (Research Square) (2023)
Open Access
Neutrosophic set and SODA based computational model for time series forecasting
Shivani Pant, Sanjay Kumar
AIP conference proceedings (2023) Vol. 2981, pp. 020033-020033
Closed Access
Page 1

Scroll to top